MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
During the last month Medtronic (NYSE:MDT) maintained its historic hold on the top of the list, with news of layoffs, regulatory wins and setbacks and some new clinical trials. Covidien (NYSE:COV) maintained the #2 spot for another month, on news of a recall, a marketing deal and its Q2 earnings report.
St. Jude Medical (NYSE:STJ) made its way back on the list with legal updates, European CE Mark wins and more, and Boston Scientific (NYSE:BSX) remained in 4th place, having hit a new 52-week high, releasing its own earnings report and posting some regulatory and acquiring a new suturing system.
DePuy Orthopaedics brought up the year, beating out its parent company Johnson & Johnson (NYSE:JNJ) while making headlines for the ongoing lawsuits over its recalled metal-on-metal hips.
Medtronic
- FDA clears Medtronic’s Affinity Fusion blood oxygenation system
- Medtronic lands U.K. approval, plans global launch for Sentrant introducer sheath
- Medtronic leads the list of the top medtech lobbying spenders of 2012
- Aussie health regulators issue 3 warnings on Medtronic insulin pumps
- Medtronic launches yet another back pain neurostim study
- The story of a stent: How Medtronic’s Resolute Integrity won FDA approval for diabetics
- Layoffs ahead for Medtronic’s spinal business
- Medtronic takes over CRM substudy in clinical trial of genetically targeted AF drug
- Edwards Lifesciences wants more from Medtronic over CoreValve infringement
- Medtronic starts trial of Valiant Mona LSA aortic stent graft
Covidien
- Covidien inks marketing deal with Vida for lung diagnostics
- Recall: Covidien pulls ventilator batteries amid defect concerns
- Covidien’s Q2 profits slide 12%
St. Jude Medical
- Patients slap St. Jude Medical with lawsuits over recalled Riata heart wires
- St. Jude lands 1st CE Mark for brain stim in treatment of involuntary muscle movement
- St. Jude-backed iRhythm Technologies raises another $16M for Zio wearable heart monitor
- FLASH: St. Jude Medical’s Q1 profits rise despite 4% sales slide
- Volcano sues St. Jude Medical again over heart pressure technology
- St. Jude Medical dips on lowered 2013 outlook
- St. Jude Medical touts European win for Allure Quadra quadripolar CRT pacemaker
Boston Scientific
- Boston Scientific hits a new high
- Allergan, Abbott, Boston Scientific chiefs make list of highest-paid U.S. public CEOs
- FDA approves Boston Scientific’s Precision Spectra pain relief device
- Boston Scientific acquires, launches fiXate suturing system
- Boston Scientific launches clinical trials for next-gen MRI-friendly pacemaker
- Boston Scientific ticks up on Q1 earnings beat despite sales slide, lowered forecast
- German court grants OrbusNeich injunction over Boston Scientific in stents patent row
DePuy Orthopaedics
- More claims that J&J knew of hip implant troubles long before issuing a recall
- Doc who designed DePuy’s metal hip tells jury he wouldn’t implant the device today
- Former FDA official testifies on behalf of DePuy in metal hip implant lawsuit
- Johnson & Johnson lands jury’s favor in 2nd metal-on-metal hip lawsuit
- Legal: DePuy aims to reverse $8.3M metal hip implant loss
- DePuy wins FDA supplemental approval for ceramic hip implant
